EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of PI3K/AKT/GLUT1 Signaling Pathway by Quercetin in the Treatment of Psoriasis

Jie Ma, Feifei Wang, Lei Wang, Ying Wang, Doudou Wu, Wenbo Jiang, Nuo Li, Yanping Bai

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl26884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Jie Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrated Traditional Chinese and Western Medicine, 100029 Beijing, …. Hauptthemen laut MEDLINE: Quercetin, Psoriasis, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is an enduring inflammatory skin disorder defined by recurring attacks, distinguished primarily by red patches and scaly skin. Quercetin, a kind of natural flavonoid compound, is widely found in various vegetables, fruits, and Chinese herbs. Quercetin is a multifaceted compound with a wide range of potential health benefits. In addition to antioxidant, cardiovascular protection, and anti-tumor effects, quercetin has shown potential in regulating immune and inflammation effects. In the initial stages, in vivo studies have demonstrated that quercetin positively affects psoriasis and is connected with the phosphatidylinositol 3-kinase (PI3K)/Protein Kinase B (AKT)/glucose transporter 1 (GLUT1) signaling. Nevertheless, the precise mechanism by which quercetin influences the PI3K/AKT/GLUT1 signaling cascade in the context of psoriasis remains uncertain.

Objective

The aim of this study was to investigate the potential therapeutic influence of quercetin on psoriasis and the relationship with the PI3K/AKT/GLUT1 signaling pathway.

Methods

A mouse model for psoriasis induced by imiquimod was employed to assess alterations in the morphology of skin lesions and their histopathological characteristics. Cell Counting kit-8 (CCK-8) assay was used to assess the impact of proliferation of HaCaT human keratinocyte cells. HaCaT cells were examined using flow cytometry for the influence of quercetin on apoptosis. Additionally, Western blot analysis was used to evaluate the protein expression levels in the PI3K/AKT/GLUT1 signaling pathway. Results: concerning pathological alterations, the mice in the model group exhibited characteristic alterations associated with psoriasis. The extent of excessive keratinization in the epidermis and hypertrophy of the spinous layer observed in each quercetin dosage group was less pronounced compared to the model group. The CCK-8 assay laid out that quercetin can suppress the proliferation of HaCaT cells. Furthermore, it was found that quercetin facilitates the apoptosis of these cells. Analysis of immunoblotting demonstrated that the intervention of quercetin in HaCaT cells led to modifications in the proteins related to the PI3K/AKT/GLUT1 signaling pathway.

Conclusion

Through in vivo and in vitro experiments, this study shows that quercetin may play a therapeutic role in psoriasis and inhibit the PI3K/AKT/GLUT1 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinPsoriasisProto-Oncogene Proteins c-aktSignal TransductionGlucose Transporter Type 1AnimalsHumansMiceCell ProliferationDisease Models, AnimalPhosphatidylinositol 3-KinasesApoptosisImiquimodHaCaT CellsSkinKeratinocytesPhosphatidylinositol 3-Kinase

Stichwörter der Autor:innen

HaCaTPI3K/AKT/GLUT1 signaling pathwayglycometabolismpsoriasisquercetin

Substanzen

QuercetinProto-Oncogene Proteins c-aktGlucose Transporter Type 1Phosphatidylinositol 3-KinasesImiquimodSLC2A1 protein, humanPhosphatidylinositol 3-Kinase

Autor:innen und Institutionen

  • Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrated Traditional Chinese and Western Medicine, 100029 Beijing, China.
  • Department of Dermatology, Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, 101300 Beijing, China.
  • China-Japan Friendship Clinical Medical College, Beijing University of Chinese Medicine, 100029 Beijing, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ma, J., Wang, F., Wang, L., Wang, Y., Wu, D., Jiang, W., Li, N., & Bai, Y. (2025). Inhibition of PI3K/AKT/GLUT1 Signaling Pathway by Quercetin in the Treatment of Psoriasis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl26884

Vancouver

Ma J, Wang F, Wang L, Wang Y, Wu D, Jiang W, et al. Inhibition of PI3K/AKT/GLUT1 Signaling Pathway by Quercetin in the Treatment of Psoriasis. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl26884

BibTeX
@article{Ma2025,
  author = {Ma, Jie and Wang, Feifei and Wang, Lei and Wang, Ying and Wu, Doudou and Jiang, Wenbo and Li, Nuo and Bai, Yanping},
  title = {Inhibition of PI3K/AKT/GLUT1 Signaling Pathway by Quercetin in the Treatment of Psoriasis},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl26884}
}
Kostenlos starten →